DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Aralen (Chloroquine) - Side Effect Reports to FDA

 
 



This is an index of side effect / adverse reaction reports (a.k.a. adverse event reports) related to Aralen (Chloroquine) and submitted to the FDA during the sample period of about a year. The information is not vetted and should not be considered as verified clinical evidence.

Reports by Event Outcome

All Cases (3)
Disability (2)

Reports by Reaction Type

Cataract (2)Anaemia (2)Vision Blurred (2)Type 2 Diabetes Mellitus (1)

Possible Aralen side effects in 53 year old female

Reported by a consumer/non-health professional from Mexico on 2012-06-29

Patient: 53 year old female, weighing 75.0 kg (165.0 pounds)

Reactions: Type 2 Diabetes Mellitus

Drug(s) suspected as cause:
Aralen

Other drugs received by patient: Methotrexate



Possible Aralen side effects in 53 year old female

Reported by a consumer/non-health professional from Mexico on 2012-04-11

Patient: 53 year old female, weighing 71.0 kg (156.2 pounds)

Reactions: Cataract, Anaemia, Vision Blurred

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Aralen
    Administration route: Oral
    Indication: Rheumatoid Arthritis
    Start date: 2008-01-01

Deflazacort
    Administration route: Oral
    Indication: Rheumatoid Arthritis
    Start date: 2008-01-01

Arava
    Administration route: Oral
    Indication: Rheumatoid Arthritis
    Start date: 2008-01-01

Methotrexate
    Administration route: Oral
    Indication: Rheumatoid Arthritis
    Start date: 2007-01-01



Possible Aralen side effects in 53 year old female

Reported by a consumer/non-health professional from Mexico on 2012-03-23

Patient: 53 year old female, weighing 71.0 kg (156.2 pounds)

Reactions: Cataract, Anaemia, Vision Blurred

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Deflazacort
    Administration route: Oral
    Indication: Rheumatoid Arthritis
    Start date: 2008-01-01

Methotrexate
    Administration route: Oral
    Indication: Rheumatoid Arthritis
    Start date: 2007-01-01

Arava
    Administration route: Oral
    Indication: Rheumatoid Arthritis
    Start date: 2008-01-01

Aralen
    Administration route: Oral
    Indication: Rheumatoid Arthritis
    Start date: 2008-01-01

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017